- Healthcare
- Social
- Retail
- Main
You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
Attachment 1
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported): October 28,
2009
ADVANCE
NANOTECH, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-10065
|
20-1614256
|
||
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
|
400
Rella Blvd, Suite 160, Montebello, NY
|
10901
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (845) 533-4225
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
1
Item
5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Effective
October 28, 2009, Joseph M. Zappulla resigned as director of the Company for
personal reasons. Mr. Zappulla was also a member of the Compensation
Committee and Chair of the Audit Committee. Mr. Zappulla’s
resignation is not the result of any disagreement between him and the Company on
any matter relating to the Company’s operations, policies or
practices.
The
Company’s Board of Directors and its Chief Executive Officer, Bret Bader,
expressed the Company's gratitude to Mr. Zappulla for his service to the
Company.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
ADVANCE
NANOTECH, INC.
By:
/s/ Thomas P. Finn
Name: Thomas
P. Finn
Title: Chief
Financial Officer & Secretary
Dated: November
3, 2009
3